Literature DB >> 1645078

An epidemiological study with risk analysis of liver diseases in the general population living in a methyl mercury polluted area.

M Futatsuka1, T Kitano, M Nagano, T Inaoka, Y Arimatsu, T Ueno, J Wakamiya, K Miyamoto.   

Abstract

STUDY
OBJECTIVE: The aim was to determine the actual prevalence of liver disease and to investigate the contribution of various risk factors to liver disease among the population in a methyl mercury polluted area.
DESIGN: The study was a population based cross sectional mass screening survey. A case-control study was designed to estimate the role of various risk factors for liver diseases.
SETTING: The study was confined to a small rural town 10 km north of Minamata City.
SUBJECTS: 1406 persons aged 50 to 69 years were examined (78.3% of the total population of this age in the locality).
MEASUREMENTS AND MAIN RESULTS: Measurements of liver disease were made on the basis of haematological, physical, and ultrasonographic examinations. Data on liver risk factors were collected by questionnaire, and by measurement of body height, weight (obesity), and hepatitis B surface antigen (HBsAg). The prevalence rate of liver tumour was 0.5% in males, liver cirrhosis was found in 0.5% of males and 0.1% of females, and hepatitis was seen in 5.4% of males and 1.0% of females. Frequency rates of risk factors for liver disease among subjects with obesity were significantly higher in the female patient group, and the frequency rate among subjects with alcoholic drinking habits was significantly higher in the male patient group. The odds ratio of past history of blood transfusion showed the highest value among other related factors (7.73) and the attributable risk for this was very high (87.1%); HBsAg was next in rank (odds ratio 3.04; attributable risk 67.1%).
CONCLUSIONS: The prevalence of liver disease in this methyl mercury polluted area was not increased, contrary to what was expected based on the standard mortality ratios. The main risk factors for liver disease in this area appear to be alcoholic drinking habits and a history of blood transfusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1645078      PMCID: PMC1059559          DOI: 10.1136/jech.46.3.237

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  3 in total

1.  Studies on the metabolism of mercuric chloride and methyl mercury dicyandiamide; experiments on rats given subcutaneous injections with radioactive mercury (Hg203).

Authors:  L FRIBERG
Journal:  AMA Arch Ind Health       Date:  1959-07

2.  Intracellular distribution of inorganic and organic mercury in rat liver after exposure to methylmercury salts.

Authors:  T Norseth; M Brendeford
Journal:  Biochem Pharmacol       Date:  1971-06       Impact factor: 5.858

3.  Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study.

Authors:  K Sakuma; T Takahara; K Okuda; F Tsuda; M Mayumi
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

  3 in total
  6 in total

1.  Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents.

Authors:  Runsen Chen; Yang Xu; Cheng Xu; Yaqin Shu; Siyu Ma; Changgui Lu; Xuming Mo
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-31       Impact factor: 4.223

Review 2.  Toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Juliane I Beier; Heather B Clair; Heather J Bellis-Jones; K Cameron Falkner; Craig J McClain; Matt C Cave
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

3.  Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.

Authors:  Matt Cave; Savitri Appana; Mihir Patel; Keith Cameron Falkner; Craig J McClain; Guy Brock
Journal:  Environ Health Perspect       Date:  2010-12       Impact factor: 9.031

4.  Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).

Authors:  Peter T Donnan; David McLernon; Douglas Steinke; Stephen Ryder; Paul Roderick; Frank M Sullivan; William Rosenberg; John F Dillon
Journal:  BMC Health Serv Res       Date:  2007-04-16       Impact factor: 2.655

5.  Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study.

Authors:  Mee-Ri Lee; Youn-Hee Lim; Bo-Eun Lee; Yun-Chul Hong
Journal:  Environ Health       Date:  2017-03-04       Impact factor: 5.984

6.  Mercury Exposure in Association With Decrease of Liver Function in Adults: A Longitudinal Study.

Authors:  Jonghyuk Choi; Sanghyuk Bae; Hyungryul Lim; Ji-Ae Lim; Yong-Han Lee; Mina Ha; Ho-Jang Kwon
Journal:  J Prev Med Public Health       Date:  2017-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.